Society for Immunotherapy of Cancer (SITC)
Emily Gronseth, PhD, is a seasoned medical writer with extensive experience in both scientific research and communication. Currently serving as a Medical Writer at the Society for Immunotherapy of Cancer since October 2020, Emily previously held positions as a Postdoctoral Fellow and Ph.D. Candidate at the Medical College of Wisconsin, where research focused on medulloblastoma and the development of a zebrafish xenotransplant confocal imaging model. Additionally, Emily's consulting work at Catalyst BioConsulting involved leading a successful rebranding campaign and managing communications and social media strategies. Earlier career experience includes roles as a Microbiology Laboratory Technician at Tufco. Emily earned a PhD in Cell Biology, Neurobiology, and Anatomy with a focus on Cancer Biology from the Medical College of Wisconsin and holds a Bachelor of Applied Science in Human Biology and Chemistry from the University of Wisconsin-Green Bay.
Society for Immunotherapy of Cancer (SITC)
The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. sitc_log_color.png Established in 1984, SITC, a 501(c)(3) not-for-profit organization, serves scientists, clinicians, academicians, patients, patient advocates, government representatives and industry leaders from around the world. Through educational programs that foster scientific exchange and collaboration, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Currently, SITC has more than 2,000 members who represent 22 medical specialties in 42 countries around the world. Through emphasis on high-caliber scientific meetings; dedication to education and outreach activities; focus on initiatives of major importance in the field; and commitment to collaborations with like-minded domestic and international organizations, government and regulatory agencies, associations and patient advocacy groups, SITC brings together all aspects of the cancer immunology and immunotherapy community. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.